Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT04393649

First Level Socio-geriatric Evaluation: ESOGER Databank

Coronavirus disease 2019 (COVID-19) is an infectious disease. Physical distancing is one of the most effective ways to reduce the spread of COVID-19, but this key prevention intervention may have adverse consequences on older adults living at home. Screening older adults living at home and at risk for adverse consequences of physical and social distancing is, therefore, a priority in order to prevent their occurrence. ESOGER ("Evaluation Social et GERiatrique") is a clinical tool designed to: 1) screen the risk-levels for adverse consequences related to COVID-19 physical distancing and 2) to continue appropriate preventive interventions in older adults living at home including frail older patients and older community dwellers. Experience cumulated during the past two weeks revealed that ESOGER could be improved, in order to be more effective and efficient for the prevention of adverse consequences related to COVID-19 physical distancing. This improvement is based on two key components: 1) Comments of Montreal ESOGER users and 2) Analysis of data. Because at this time no information is saved and stored, there is a need to save and store ESOGER information and create the ESOGER databank.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

70 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Jewish General Hospital

Montreal, Quebec, H3T 1E2, Canada

Who can participate

Only the study team can determine whether someone qualifies for participation.

The inclusion criteria are:

  • Older (i.e., 70-years-old and over) adults OR caregiver living at home with an adult answering to inclusion criteria
  • Living and staying at home because of physical and social distancing
  • Understanding and writing the different languages of the recruitment centre (i.e., French, English, Chinese.)
  • Agree to participate in the study

The exclusion criteria are:

  • A concomitant participation to another medical trial
  • Living in semi-autonomous residence or CHSLD

Treatment and study plan

ESOGER

Other

Questionnaire

Primary outcomes

  1. COVID-19 symptoms

    Time frame: 1 day

    presence or not of fever, cough and shortness of breath (binary question)

  2. issues related to medication and food delivery and access to home care

    Time frame: 1 day

    presence or not of a rupture of access to food, medication and home care (binary question)

  3. physical frailty

    Time frame: 1 day

    Questionnaire Emergency Room Evaluation and Recommandation (ER2), score from 0 = no risk of frailty to 14 = high risk of frailty)

  4. psychological frailty

    Time frame: 1 day

    anxiety Verbal analogic scale, score from 0 = no anxiety to 10 = extremely anxious)

Secondary outcomes

  1. Caregiver burden

    Time frame: 1 day

    Zarit scale, score from 0 = no caregiver burden to 16 = high caregiver burden)

Sponsors and collaborators

Lead sponsor

Jewish General Hospital

Other

Registry information

Official study title

First Level Socio-geriatric Evaluation in Period of Physical and Social Distancing in Frail Older Patients and Older Community Dwellers: ESOGER Databank

Important dates

Study start
2020
Primary completion
2027
Study completion
2027
First posted
May 19, 2020
Registry last updated
Feb 23, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.